Patulin and Xestoquinol are inhibitors of DNA topoisomerase 1
Proceedings of the National Academy of Sciences · 2025
DOI: 10.1073/pnas.2421167122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Emanuela Tumini und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genome Biology, Centro Andaluz de Biología Molecular y Medicina Regenerativa, Universidad de Sevilla, Seville, Spain. Hauptthemen laut MEDLINE: Patulin, DNA Topoisomerases, Type I, Topoisomerase I Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España (MINECO), Ministerio de Ciencia e Innovación (MCIN), EC | ERC | HORIZON EUROPE European Research Council (ERC).
Abstract (Originalsprache)
DNA topoisomerase 1 (TOP1) is essential for transcription, replication, and repair. Its function relies on two catalytic steps, DNA breakage and rejoining. Inhibitors of the second step prevent DNA rejoining and lead to persistent DNA breaks, acting as topoisomerase poisons, used as anticancer drugs. However, reliable inhibitors of the first step are not available. Here, we provide genetic and molecular evidence supporting that Patulin and, to a lesser extent, Xestoquinol inhibit the first catalytic step of TOP1 in vitro, in yeast and in human cells. Particularly, Patulin prevents the accumulation of TOP1 cleavage complexes caused by the TOP1 poison camptothecin (CPT) in human cells. Moreover, Patulin pretreatment of human or yeast cells reduces DNA damage and the accumulation of DNA breaks upon CPT exposure. Consistent with the protective role of TOP1 against harmful R-loops, Patulin treatment increases R-loops and R-loop-associated cytotoxicity, mimicking the effect of TOP1 silencing. Altogether our findings indicate that Patulin and Xestoquinol are nonpoisoning inhibitors of TOP1, which should potentiate new research approaches in molecular biology and medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genome Biology, Centro Andaluz de Biología Molecular y Medicina Regenerativa, Universidad de Sevilla, Seville, Spain.
- Departamento de Genética, Facultad de Biología, Universidad de Sevilla, Seville 41092, Spain.
- Research and Development, Oncology Business Unit, PharmaMar Sociedad Anónima, Madrid 28770, Spain.
ORCID-Profile: Emanuela Tumini, Ralf E Wellinger, Emilia Herrera-Moyano, Patricia Navarro-Cansino, María García-Rubio, Hélène Gaillard, Rosa Luna, Andrés Aguilera
Förderung
- Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España (MINECO)
- Ministerio de Ciencia e Innovación (MCIN)
- EC | ERC | HORIZON EUROPE European Research Council (ERC)
Zitieren
APA
Tumini, E., Wellinger, R. E., Herrera-Moyano, E., Navarro-Cansino, P., García-Rubio, M., Salas-Lloret, D., Losada, A., Muñoz-Alonso, M. J., Gaillard, H., Luna, R., & Aguilera, A. (2025). Patulin and Xestoquinol are inhibitors of DNA topoisomerase 1. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2421167122
Vancouver
Tumini E, Wellinger RE, Herrera-Moyano E, Navarro-Cansino P, García-Rubio M, Salas-Lloret D, et al. Patulin and Xestoquinol are inhibitors of DNA topoisomerase 1. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2421167122
BibTeX
@article{Tumini2025,
author = {Tumini, Emanuela and Wellinger, Ralf E and Herrera-Moyano, Emilia and Navarro-Cansino, Patricia and García-Rubio, María and Salas-Lloret, Daniel and Losada, Alejandro and Muñoz-Alonso, María J and Gaillard, Hélène and Luna, Rosa and Aguilera, Andrés},
title = {Patulin and Xestoquinol are inhibitors of DNA topoisomerase 1},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
doi = {10.1073/pnas.2421167122}
}
EUVIMED